HCA Healthcare Cash & Equivalents increased by 4.3% to $1.04B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 46.2%, from $1.93B to $1.04B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -10.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.12B | $1.03B | $1.45B | $2.37B | $858.00M | $999.00M | $908.00M | $842.00M | $862.00M | $891.00M | $935.00M | $1.28B | $831.00M | $2.89B | $1.93B | $1.06B | $939.00M | $997.00M | $1.04B |
| QoQ Change | — | -8.3% | +41.3% | +63.4% | -63.8% | +16.4% | -9.1% | -7.3% | +2.4% | +3.4% | +4.9% | +37.3% | -35.3% | +247.5% | -33.1% | -45.2% | -11.4% | +6.2% | +4.3% |
| YoY Change | — | — | — | — | -23.4% | -2.7% | -37.4% | -64.5% | +0.5% | -10.8% | +3.0% | +52.5% | -3.6% | +224.1% | +106.7% | -17.4% | +13.0% | -65.5% | -46.2% |